tirzepatide dementia study A preliminary of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 GLP-1s Could Protect Against Neurodegeneration,

Higher doses have been shown to bring more nausea 1 , but again, this typically eases as the body adjusts to the dose

Michael Nusbaum, our team provides the expert care necessary for a lifelong transformation

Always remember that your doctor is there to help you too.

I think this is more of a problem for small molecule drugs, because its really easy for generics to develop their own version of the small molecule drug in general

The basic biochemistry is well-established: it is a real endogenous peptide, it genuinely binds copper, it declines with age, and it produces measurable effects on collagen synthesis, wound healing, and gene expression

doi:10.1210/clinem/dgaa863